Effectiveness of Ivermectin in preventing development of symptomatic Covid-19 among primary contacts of newly diagnosed Covid-19 positive patients at a tertiary care hospital in North India - an interventional study

Department of Community Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•All the family members of a newly diagnosed Covid-19 patient who are - living with the patient in the last 2 weeks, aged between 18 years and 60 years of age, asymptomatic on the day of diagnosis of the index case.

•The following will be excluded from the study:
•1. Pregnant or lactating women
•2. Those with any degree of ARI symptoms or fever.
•3. Person with known history of severe hypersensitivity reaction to previous exposure to Ivermectin.
•4. People with pre-existng severe medical conditions according to the judgement of
•the investigators

发起方

Department of Community Medicine